Lipid accumulation product and type 2 diabetes risk: a population-based study.
Lipid accumulation product
Triglyceride
Type 2 diabetes
Waist circumference
Journal
BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676
Informations de publication
Date de publication:
12 Aug 2024
12 Aug 2024
Historique:
received:
25
05
2024
accepted:
07
08
2024
medline:
13
8
2024
pubmed:
13
8
2024
entrez:
12
8
2024
Statut:
epublish
Résumé
The Lipid Accumulation Product (LAP) is a measure that indicates excessive fat accumulation in the body. LAP has been the focus of research in epidemiological studies aimed at forecasting chronic and metabolic diseases. This study aimed to evaluate the association between LAP and type 2 diabetes mellitus (T2DM) among adults in western Iran. The study involved 9,065 adults who participated in the initial phase of the Ravansar non-communicable diseases study (RaNCD) cohort. To investigate the association between LAP and T2DM, multiple logistic regressions were employed. Additionally, the receiver operating characteristic (ROC) curve was used to evaluate LAP's predictive ability concerning T2DM. The participants had an average age of 47.24 ± 8.27 years, comprising 49.30% men and 50.70% women. The mean LAP was 53.10 ± 36.60 for the healthy group and 75.51 ± 51.34 for the diabetic group (P < 0.001). The multiple regression analysis revealed that the odds of T2DM in the second quartile of LAP were 1.69 (95% CI: 1.25, 2.29) times greater than in the first quartile. Furthermore, the odds in the third and fourth quartiles were 2.67 (95% CI: 2.01, 3.55) and 3.73 (95% CI: 2.83, 4.92) times higher, respectively. The ROC analysis for predicting T2DM showed that the LAP index had an area under the curve (AUC) of 0.66 (95% CI: 0.64, 0.68). A strong association was identified between elevated LAP levels and T2DM in the adult population of western Iran. LAP is recommended as a potential tool for screening diabetes susceptibility.
Sections du résumé
BACKGROUND
BACKGROUND
The Lipid Accumulation Product (LAP) is a measure that indicates excessive fat accumulation in the body. LAP has been the focus of research in epidemiological studies aimed at forecasting chronic and metabolic diseases. This study aimed to evaluate the association between LAP and type 2 diabetes mellitus (T2DM) among adults in western Iran.
METHODS
METHODS
The study involved 9,065 adults who participated in the initial phase of the Ravansar non-communicable diseases study (RaNCD) cohort. To investigate the association between LAP and T2DM, multiple logistic regressions were employed. Additionally, the receiver operating characteristic (ROC) curve was used to evaluate LAP's predictive ability concerning T2DM.
RESULTS
RESULTS
The participants had an average age of 47.24 ± 8.27 years, comprising 49.30% men and 50.70% women. The mean LAP was 53.10 ± 36.60 for the healthy group and 75.51 ± 51.34 for the diabetic group (P < 0.001). The multiple regression analysis revealed that the odds of T2DM in the second quartile of LAP were 1.69 (95% CI: 1.25, 2.29) times greater than in the first quartile. Furthermore, the odds in the third and fourth quartiles were 2.67 (95% CI: 2.01, 3.55) and 3.73 (95% CI: 2.83, 4.92) times higher, respectively. The ROC analysis for predicting T2DM showed that the LAP index had an area under the curve (AUC) of 0.66 (95% CI: 0.64, 0.68).
CONCLUSION
CONCLUSIONS
A strong association was identified between elevated LAP levels and T2DM in the adult population of western Iran. LAP is recommended as a potential tool for screening diabetes susceptibility.
Identifiants
pubmed: 39134995
doi: 10.1186/s12902-024-01682-6
pii: 10.1186/s12902-024-01682-6
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
147Informations de copyright
© 2024. The Author(s).
Références
Budreviciute A, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8:788.
doi: 10.3389/fpubh.2020.574111
Institute for Health Metrics and Evaluation (IHME). GBD Compare Seattle, WA: IHME,University of Washington2015 [ https://vizhub.healthdata.org/gbd-compare/
Khosravi Shadmani F, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: a modeling study. PLoS ONE. 2019;14:e0211622.
doi: 10.1371/journal.pone.0211622
pubmed: 30763320
pmcid: 6375574
Valencia WM, Florez H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ 356 (2017).
Gong Q, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019;7:452–61.
doi: 10.1016/S2213-8587(19)30093-2
pubmed: 31036503
pmcid: 8172050
Klein S, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004;80:257–63.
doi: 10.1093/ajcn/80.2.257
pubmed: 15277143
Zhang F-L et al. Strong Association of waist circumference (WC), body mass index (BMI), waist-to-height ratio (WHtR), and waist-to-hip ratio (WHR) with diabetes: A population-based cross-sectional study in Jilin province, China. Journal of diabetes research 2021 (2021).
Wei J, Liu X, Xue H, Wang Y, Shi Z. Comparisons of visceral adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults. Nutrients. 2019;11:1580.
doi: 10.3390/nu11071580
pubmed: 31336951
pmcid: 6683101
Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–77.
doi: 10.1038/nrm2391
pubmed: 18401346
pmcid: 2886982
Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW. Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45 to 64 years. Ann Intern Med. 2009;150:741–51.
doi: 10.7326/0003-4819-150-11-200906020-00002
pubmed: 19487709
Sattar N, Wannamethee S, Forouhi N. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia. 2008;51:926–40.
doi: 10.1007/s00125-008-0954-7
pubmed: 18392804
Unger RH. Reinventing type 2 diabetes: pathogenesis, treatment, and prevention. JAMA. 2008;299:1185–7.
doi: 10.1001/jama.299.10.1185
pubmed: 18334695
Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-lnsulin-dependent diabetes mellitus: a prospective cohort study of men in the normative aging study. Am J Epidemiol. 1992;136:1474–86.
doi: 10.1093/oxfordjournals.aje.a116468
pubmed: 1288277
Schulze MB, et al. Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study. Diabetes Care. 2006;29:1921–3.
doi: 10.2337/dc06-0895
pubmed: 16873804
Yang W, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101.
doi: 10.1056/NEJMoa0908292
pubmed: 20335585
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Reviews Endocrinol. 2018;14:88–98.
doi: 10.1038/nrendo.2017.151
Cai X et al. Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study. Disease markers 2022, 3150380 (2022).
Cai X-T et al. Associations between the metabolic score for insulin resistance index and the risk of type 2 diabetes mellitus among non-obese adults: insights from a population-based cohort study. Int J Gen Med, 7729–40 (2021).
Hamzeh B, et al. Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran. Lipids Health Dis. 2021;20:1–10.
doi: 10.1186/s12944-021-01505-w
Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian population. Metab Syndr Relat Disord. 2018;16:240–5.
doi: 10.1089/met.2017.0119
pubmed: 29648916
Muheiyati G, Mei Y, Tao N. Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China. PeerJ. 2023;11:e15273.
doi: 10.7717/peerj.15273
pubmed: 37214102
pmcid: 10199676
Vieira JN, et al. Cardiovascular risk assessment using the lipid accumulation product index among primary healthcare users: a cross-sectional study. Sao Paulo Med J. 2019;137:126–31.
doi: 10.1590/1516-3180.2018.0293240119
pubmed: 31314872
pmcid: 9721238
Liu T, et al. Relationship between lipid accumulation product and new-onset diabetes in the Japanese population: a retrospective cohort study. Front Endocrinol. 2023;14:1181941.
doi: 10.3389/fendo.2023.1181941
Pasdar Y, et al. Cohort profile: Ravansar Non-communicable Disease cohort study: the first cohort study in a kurdish population. Int J Epidemiol. 2019;48:682–f683.
doi: 10.1093/ije/dyy296
pubmed: 30753701
Poustchi H, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2018;187:647–55.
doi: 10.1093/aje/kwx314
pubmed: 29145581
Najafi F, et al. Decomposing socioeconomic inequality in dental caries in Iran: cross-sectional results from the PERSIAN cohort study. Archives Public Health. 2020;78:1–11.
doi: 10.1186/s13690-020-00457-4
Ching YK, Chin YS, Appukutty M, Gan WY, Chan YM. Comparisons of conventional and novel anthropometric obesity indices to predict metabolic syndrome among vegetarians in Malaysia. Sci Rep. 2020;10:20861.
doi: 10.1038/s41598-020-78035-5
pubmed: 33257810
pmcid: 7705716
Chobanian AV. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
doi: 10.1001/jama.289.19.2560
pubmed: 12748199
Glaser AN. High-yield biostatistics, epidemiology, and public health. Lippincott Williams & Wilkins; 2013.
Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.
doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
pubmed: 15405679
Yan G, et al. Association of lipid accumulation product trajectories with 5-year incidence of type 2 diabetes in Chinese adults: a cohort study. Nutr Metabolism. 2019;16:1–8.
doi: 10.1186/s12986-019-0399-7
Lee J-W, Lim N-K, Park H-Y. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged koreans. BMC Endocr Disorders. 2018;18:1–10.
doi: 10.1186/s12902-018-0259-x
Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31–55.
doi: 10.1016/j.immuni.2021.12.013
pubmed: 35021057
pmcid: 8773457
Kang PS, Neeland IJ. Body Fat distribution, diabetes Mellitus, and Cardiovascular Disease: an update. Curr Cardiol Rep. 2023;25:1555–64.
doi: 10.1007/s11886-023-01969-5
pubmed: 37792133
Kane JP, Pullinger CR, Goldfine ID, Malloy MJ. Dyslipidemia and Diabetes Mellitus: role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus. Curr Opin Pharmacol. 2021;61:21–7.
doi: 10.1016/j.coph.2021.08.013
pubmed: 34562838
Song J, et al. The effect of lipid accumulation product and its interaction with other factors on hypertension risk in Chinese Han population: a cross-sectional study. PLoS ONE. 2018;13:e0198105.
doi: 10.1371/journal.pone.0198105
pubmed: 29874254
pmcid: 5991403
Lu J, Zhao J, Meng H, Zhang X. Adipose tissue-resident immune cells in obesity and type 2 diabetes. Front Immunol. 2019;10:1173.
doi: 10.3389/fimmu.2019.01173
pubmed: 31191541
pmcid: 6540829
Hanson P, Weickert MO, Barber TM. Obesity: novel and unusual predisposing factors. Therapeutic Adv Endocrinol Metabolism. 2020;11:2042018820922018.
doi: 10.1177/2042018820922018
Di Meo S, Iossa S, Venditti P. Skeletal muscle insulin resistance: role of mitochondria and other ROS sources. J Endocrinol. 2017;233:R15–42.
doi: 10.1530/JOE-16-0598
pubmed: 28232636
Kim O-K, Jun W, Lee J. Mechanism of ER stress and inflammation for hepatic insulin resistance in obesity. Annals Nutr Metabolism. 2015;67:218–27.
doi: 10.1159/000440905
Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–80.
doi: 10.1053/j.gastro.2007.03.059
pubmed: 17498510
Jacqueminet S, Briaud I, Rouault C, Reach G, Poitout V. Inhibition of insulin gene expression by long-term exposure of pancreatic β cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism. 2000;49:532–6.
doi: 10.1016/S0026-0495(00)80021-9
pubmed: 10778881
Maedler K, et al. Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function. Diabetes. 2001;50:69–76.
doi: 10.2337/diabetes.50.1.69
pubmed: 11147797
Yang SH, Yoon J, Lee Y-J, Park B, Jung D-H. Lipid accumulation product index predicts new-onset type 2 diabetes among non-obese koreans: a 12-year longitudinal study. Diabetes Metabolic Syndrome Obesity: Targets Therapy, 3729–37 (2022).
Lin C-Y, et al. Comparison of lipid accumulation product and visceral adiposity index with traditional obesity indices in early-onset type 2 diabetes prediction: a cross-sectional study. Diabetol Metab Syndr. 2023;15:111.
doi: 10.1186/s13098-023-01056-3
pubmed: 37237396
pmcid: 10223887